Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...
The Cambridge-based company’s latest COVID shot was approved three weeks earlier than last year, according to a statement ...
Leerink Partners analyst Mani Foroohar assigned a Sell rating on Moderna (MRNA – Research Report) on November 7 and set a price target of ...
Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...
Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar with the matter.
Coegi used more than 500 million impressions and paid social optimized with attention and emotion metrics to drive 24% of ...
Heading into Moderna’s third-quarter earnings, investors and analysts will be watching to see how the Cambridge drugmaker ...
Moderna reported earnings that exceeded expectations due to effective cost management but still has challenges related to its ...
Barchart on MSN2d
Moderna Stock Outlook: Is Wall Street Bullish or Bearish?Headquartered in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a biotechnology company specializing in messenger RNA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback